Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Salvage therapy with amprenavir and ritonavir: prospective study in 17 heavily pretreated patients.

HIV clinical trials - 1 Jan 2000

Arvieux Cédric, Tattevin Pierre, Souala Faouzi M, Jaccard Philippe, Ruffault Annick, Bentué-Ferrer Danielle, Tribut Olivier, Chapplain Jean-Marc, Dupont Mathieu, Bouvier Cécile, Michelet Christian

Abstract excerpt

OBJECTIVE: To evaluate the safety profile and efficacy of salvage regimens containing amprenavir (APV) 600 mg twice daily and ritonavir (RTV) 200 mg twice daily. DESIGN: Prospective, single-center study. METHOD: The patient database of the department of infectious diseases was screened for patients who had failed at least two successive three-drug combinations. These patients were proposed to take APV and RTV in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamates
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Furans

Share to HIV Protease Inhibitors

Share to Patient Compliance

Share to Ritonavir

Share to Salvage Therapy

Share to Sulfonamides

Source

Identifiers

PMID: 11976990
DOI: 10.1310/RFT5-7N0M-8C5G-0TL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Salvage therapy with amprenavir and ritonavir: prospective study in 17 heavily pretreated patients.PMID 11976990Read ↗

Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens.Semantic proximity Read ↗

Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial.Semantic proximity Read ↗

Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.Semantic proximity Read ↗

Amprenavir in pre-treated patients: virological and immunological response in a cohort of 45 patients.Semantic proximity Read ↗

A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience.Semantic proximity Read ↗

Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome.Semantic proximity Read ↗

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients.Semantic proximity Read ↗

Failure of HIV-1 protease inhibitors to fully suppress viral replication. Implications for salvage therapy.Semantic proximity Read ↗

Salvage therapy for patients failing their current antiretroviral regimen.Semantic proximity Read ↗

Performance of six different ritonavir-boosted protease inhibitor-based regimens in heavily antiretroviral-experienced HIV-infected patients.Semantic proximity Read ↗

Salvage treatment with lopinavir/ritonavir (Kaletra) in HIV-infected patients failing all current antiretroviral drug families.Semantic proximity Read ↗

Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.